Gene · 6613
Papers2,290
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,290
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia. | Cell Death Dis | 2023 | 36810326 | PubTator, text mining | PubMed |
| Proximity labeling reveals a new in vivo network of interactors for the histone demethylase KDM5. | Epigenetics Chromatin | 2023 | 36803422 | PubTator, text mining | PubMed |
| Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer. | Theranostics | 2023 | 36793866 | PubTator, text mining | PubMed |
| Inhibition of SUMOylation enhances DNA hypomethylating drug efficacy to reduce outgrowth of hematopoietic malignancies. | Leukemia | 2023 | 36792656 | PubTator, text mining | PubMed |
| Crosstalk between PML and p53 in response to TGF-β1: A new mechanism of cardiac fibroblast activation. | Int J Biol Sci | 2023 | 36778116 | PubTator, text mining | PubMed |
| Development and Recent Advances in Lysine and N-Terminal Bioconjugation for Peptides and Proteins. | Molecules | 2023 | 36770752 | PubTator, text mining | PubMed |
| Skeletal Muscles of Sedentary and Physically Active Aged People Have Distinctive Genic Extrachromosomal Circular DNA Profiles. | Int J Mol Sci | 2023 | 36769072 | PubTator, text mining | PubMed |
| Aurora B SUMOylation Is Restricted to Centromeres in Early Mitosis and Requires RANBP2. | Cells | 2023 | 36766713 | PubTator, text mining | PubMed |
| Alternative splicing of the SUMO1/2/3 transcripts affects cellular SUMOylation and produces functionally distinct SUMO protein isoforms. | Sci Rep | 2023 | 36759644 | PubTator, text mining | PubMed |
| Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha. | Cancer Discov | 2023 | 36745048 | PubTator, text mining | PubMed |
| The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis. | Oncogene | 2023 | 36732658 | PubTator, text mining | PubMed |
| USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination. | Cell Oncol (Dordr) | 2023 | 36732432 | PubTator, text mining | PubMed |
| Gene expression profiles and bioinformatics analysis in lung samples from ovalbumin-induced asthmatic mice. | BMC Pulm Med | 2023 | 36726128 | PubTator, text mining | PubMed |
| SUMO Proteomics Analyses Identify Protein Inhibitor of Activated STAT-Mediated Regulatory Networks Involved in Cell Cycle and Cell Proliferation. | J Proteome Res | 2023 | 36723483 | PubTator, text mining | PubMed |
| Sumoylation is Largely Dispensable for Normal Growth but Facilitates Heat Tolerance in Yeast. | Mol Cell Biol | 2023 | 36720466 | PubTator, text mining | PubMed |
| SUMOylation-mediated PSME3-20S proteasomal degradation of transcription factor CP2c is crucial for cell cycle progression. | Sci Adv | 2023 | 36706181 | PubTator, text mining | PubMed |
| SUMOylation of HNRNPA2B1 modulates RPA dynamics during unperturbed replication and genotoxic stress responses. | Mol Cell | 2023 | 36702126 | PubTator, text mining | PubMed |
| Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2. | Eur J Med Chem | 2023 | 36702052 | PubTator, text mining | PubMed |
| A New Potential Therapeutic Target for Cancer in Ubiquitin-Like Proteins-UBL3. | Int J Mol Sci | 2023 | 36674743 | PubTator, text mining | PubMed |
| Species-specific self-DNA detection mechanisms by mammalian cyclic GMP-AMP synthases. | Sci Immunol | 2023 | 36662885 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6613/papers?page=13